Nucleic Acid Isolation and Purification Market Report | Size, Growth, Opportunities and Forecast 2022-2029

 The Global Nucleic Acid Isolation And Purification Market is anticipated to reach US$ 994 million by 2022.

 Rising government and commercial sector investment in the development of novel biotechnological diagnostic procedures, as well as the growing need to identify and define microbial diversity, are driving market demand.

With growing need to understand and characterize microbial diversity, including that associated with human body, governments as well as private companies are increasingly investing in life science projects, thereby creating a greater demand for nucleic acid isolation and purification. While the high cost challenge persists, shortage of skilled professionals in healthcare and biopharma industries remain the longstanding challenges.

Get Full Access: https://www.futuremarketinsights.com/reports/nucleic-acid-isolation-and-purification-market

“Rapid and efficient methods or products to extract genomic RNA and DNA from virtually any biological sample have been growing in demand to ensure the success of downstream applications in molecular biology. With growing research on detection of tumor specific changes, FMI study finds that nucleic acid isolation and purification market vendors are exploring new technologies to facilitate ease-of-use and minimize user-error of their products.”

Future market Insights' study reveals that the nucleic acid isolation and purification market is likely to expand at a CAGR of ~5% during the period 2019-2029. One of the key influencing factors is manufacturers' focus to direct their investments towards advanced technologies such as magnetic-bead or bead-beating technology, to align with end users' demand for an effective system for extraction of high-quality starting material and efficient inhibitor removal. The unique challenges for extracting and purifying nucleic acid from different organisms and tissue types, have also brought more focus on customized systems and solutions.

Advances in Microbiome Research to Dictate Manufacturers’ Growth Strategies

In comparison with RNA isolation kits, manufacturers continue to increase innovations and production of DNA isolation kits, as the category is expected to account for larger share in the market during the forecast period. As per the study, lucrative opportunities are identified in increasing application scope of DNA isolation and purification kits in various academic research institutes, contract research organizations, and biotechnologies companies to not only successfully extract the DNA but also to minimize the presence of contaminants and prevent nucleic acid degradation during preparation. As genomic and microbiome research advances, manufacturers are working on automating the nucleic acid isolation and purifications kits to recover DNA and RNA from the toughest samples used in microbiome work such as soil and stool samples.

Growth prospects of the nucleic acid isolation and purification market, as the study opines, are relatively high in developed countries of North America and Europe. Hefty investments in R&D on molecular biology and precision medicines over gradual increase in the prevalence of cancer, genetic disorders, and complex diseases are likely to influence the manufacturers to enhance their production capabilities.

Key Companies Profiled:

·         QIAGEN

·         Thermo Fisher Scientific, Inc.

·         Illumina, Inc.  

·         F. Hoffmann-La Roche AG

·         Merck KGaA

·         Agilent Technologies

·         Bio-Rad Laboratories, Inc.

·         Takara Bio, Inc.

·         Promega Corporation

·         New England Biolabs

·         LGC Limited

·         Abcam plc

·         Norgen Biotek Corp

·         AutoGen, Inc.

·         Biogenuix

·         PCR Biosystems, Inc.

·         MagGenome

·         Apical Scientific Sdn. Bhd

·         MACHEREY-NAGEL GmbH & Co. KG